- Home
- Products
Ventavis (Iloprost)
Ventavis (Iloprost)
- Medicine Name: VENTAVIS®
- Generic Name: Iloprost Trometamol
- Dosage Form & Strength: 1 mL ampoules in two concentrations – 10 mcg/mL and 20 mcg/mL
- Route of Administration: Inhalation via I-neb AAD System
- Manufactured By: CoTherix, Inc.
VENTAVIS® (Iloprost) is a synthetic analog of prostacyclin indicated for the treatment of adult patients with severe pulmonary arterial hypertension (PAH) (WHO Group I). This condition involves high blood pressure in the arteries of the lungs, and VENTAVIS works by dilating blood vessels to improve blood flow and relieve PAH symptoms.
Therapeutic Benefits:
- Helps improve exercise capacity
- Reduces symptoms related to PAH
- Administered via inhalation for targeted pulmonary effect
Recommended Dosage:
- Start with 2.5 mcg per inhalation, and increase to 5 mcg if tolerated
- Use 6 to 9 times daily, with at least 2-hour intervals between doses
- Maximum daily dose: 45 mcg
- 20 mcg/mL concentration is preferred for patients requiring reduced inhalation times
Note: Not studied in pediatric populations (under 18 years of age).
Avoid skin or eye contact and oral ingestion of the inhalation solution
Do not initiate therapy in patients with systolic blood pressure <85 mmHg
Risk of syncope may increase with exertion
Pulmonary edema could indicate pulmonary venous hypertension — discontinue if signs occur
Bronchospasm risk: Especially in patients with asthma, COPD, or hyperreactive airways
Iloprost use in acute pulmonary infections has not been evaluated
To legally import VENTAVIS (Iloprost Trometamol) into India via Global Rare Meds, the following documents are required:
Required Documentation:
- Valid prescription from a pulmonologist or cardiologist
- Diagnostic reports confirming PAH
- Government-issued patient ID
- Import permit (if applicable)
Availability in India:
VENTAVIS is not commercially available in India. Global Rare Meds enables named-patient imports to major cities such as Mumbai, Delhi, Chennai, Hyderabad, Bengaluru, Pune, Kolkata, Ahmedabad, Lucknow, and others.
📧 Email: info@globalraremeds.com
📞 Call / WhatsApp: +91-99675 15602
Global Rare Meds ensures verified and timely delivery of VENTAVIS through:
- Sourcing from certified suppliers in the USA, Canada, Europe, and Australia
- Dispensing only against valid prescriptions
- Orders shipped via cold-chain logistics from our fulfillment center in Ambernath, Thane District
- Delivery across India and international locations
Q1: What is the generic name of VENTAVIS®?
A: The generic name is Iloprost Trometamol.
Q2: Who manufactures VENTAVIS®?
A: Manufactured by CoTherix, Inc.
Q3: Is VENTAVIS® approved by the FDA?
A: Yes. FDA approval was granted on December 29, 2004.
Q4: What dosage forms are available?
A: VENTAVIS is supplied in 1 mL ampoules in 10 mcg/mL and 20 mcg/mL concentrations for inhalation.
Q5: What are the common side effects of VENTAVIS®?
A:
- Cough, flushing, headache, hypotension
- Nausea, vomiting, muscle cramps
- Tongue pain, palpitations, back pain
- Trismus, insomnia, hemoptysis, pneumonia
Q6: How much does VENTAVIS® cost in India?
A: Cost may vary by source and quantity. Contact us at +91-99675 15602 or email info@globalraremeds.com for current pricing.
Q7: What are the storage guidelines?
A: Store at 20–25°C (68–77°F). Excursions permitted between 15–30°C (59–86°F). Keep in original packaging.
Q8: Can I order VENTAVIS® online in India?
A: Yes, Global Rare Meds provides authentic, legally sourced supply of VENTAVIS under named-patient import regulations.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
